Medpace Holdings revenue and financials
$602.90Change from previous close: −2.84%Absolute change: −$17.61
In the fiscal year ended December 2025, Medpace Holdings reported revenue of $2.53B (+19.97% year over year). Net income was $451.12M, a net margin of 17.8%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +19.97%
- 2025 vs 2024
- Net income growth
- +11.56%
- 2025 vs 2024
- Net margin
- 17.8%
- 2024: 19.2%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 162 | 152 | 193 | 246 | 149 | 126 | 191 | 149 | 116 | 153 | 156 | 114 |
| Depreciation and amortization | 6.7 | 6.9 | 7.1 | 7.0 | 7.0 | 6.9 | 7.5 | 7.5 | 7.2 | 7.0 | 7.0 | 6.9 |
| Capital expenditure | -23.9 | -6.8 | -4.5 | -10.7 | -6.1 | -10.0 | -7.6 | -10.5 | -12.9 | -5.5 | -10.0 | -8.7 |
| Investing cash flow | -23.9 | -6.7 | -4.5 | -10.7 | -6.0 | -10.0 | -7.6 | -10.5 | -12.8 | 2.5 | -8.0 | -8.7 |
| Financing cash flow | -288 | 12.7 | 22.7 | 3.4 | -541 | -346 | -169 | 6.3 | 0.7 | 7.7 | 1.5 | -49.3 |
| Share repurchases | -295 | 0.0 | 0.0 | -4.6 | -541 | -372 | -170 | — | — | — | — | — |
| Debt repaid | — | — | — | — | — | — | — | — | — | — | — | -55.0 |
| Effect of exchange rates | 0.2 | -2.1 | 0.8 | 0.1 | 3.0 | 2.1 | -2.0 | 1.1 | -0.4 | -1.3 | 0.3 | -0.4 |
| Net change in cash | -150 | 156 | 212 | 239 | -395 | -228 | 12.5 | 146 | 104 | 162 | 150 | 56.1 |
| Free cash flow | 138 | 145 | 188 | 235 | 142 | 116 | 183 | 139 | 104 | 147 | 146 | 106 |
| Levered free cash flow | 108 | 100 | 125 | 177 | 88.3 | 81.9 | 164 | 111 | 76.4 | 113 | 137 | 93.1 |